Blog

Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS

Photo taken from Nico Gagelmann/X

May 12, 2024, 04:15

Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS

Nico Gagelmann, shared on LinkedIn

“Finally out!

Huge congratulations to Matteo G Della Porta and all contributors to this big achievement in JCO on timing of transplantation for patients with MDS.

These results provide evidence for the clinical relevance of including genomic features into the transplantation decision making process, allowing personalizing the hazards and effectiveness of HSCT in patients with MDS.”

Nico Gagelmann
OncoDaily

Read the article.
Source: Nico Gagelmann/LinkedIn

cancer cancer treatment Genomic Features hematopoietic stem cell transplantation HSCT JCO Journal of Clinical Oncology Matteo G Della Porta MDS Medical Research myelodysplastic syndromes Nico Gagelmann OncoDaily Oncology personalized medicine Transplant Timing

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage